EBR Systems (EBRCZ) Current Deferred Revenue (2025 - 2026)

EBR Systems' (EBRCZ) quarterly Current Deferred Revenue came in at $1.1 million in Q1 2026, up 119.12% quarter-over-quarter from $502000.0 in Q4 2025.

EBR Systems (EBRCZ) Current Deferred Revenue (2025 - 2026) Analysis & Trends

EBR Systems has disclosed Current Deferred Revenue across 2 years of filings, most recently posting $1.1 million for Q1 2026.

  • Current Deferred Revenue for Q1 2026 came in at $1.1 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (changed N/A YoY), and the FY2025 annual result was $502000.0, changed N/A from the prior year.
  • Current Deferred Revenue came in at $1.1 million for Q1 2026 at EBR Systems, up from $502000.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $1.1 million in Q1 2026 to a low of $502000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 EBR Systems - - 184,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 1.10 Mn
Dec 31, 2025 502,000.00